(Q54458545)

30 May 2018

title

Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis. (English)

1 reference

30 May 2018

0 references

P Christadoss

1

1 reference

30 May 2018

J M Lindstrom

series ordinal

2

1 reference

30 May 2018

R W Melvold

series ordinal

3

1 reference

30 May 2018

N Talal

series ordinal

4

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 January 1985

1 reference

30 May 2018

published in

Immunogenetics

1 reference

30 May 2018

volume

21

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

33-38

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/bf00372239

exact match

0 references

cites work

Autoimmune Response to Acetylcholine Receptors in Myasthenia Gravis and Its Animal Model

1 reference

12 December 2020

HLA antigens and myasthenia gravis in Japan

1 reference

12 December 2020

HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis

1 reference

12 December 2020

Reconstitution of Ir genes, Ia antigens, and mixed lymphocyte reaction determinants by gene complementation

1 reference

12 December 2020

Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis

1 reference

12 December 2020

Genetic control of experimental autoimmune myasthenia gravis in mice. I. Lymphocyte proliferative response to acetylcholine receptors is under H-2-linked Ir gene control

1 reference

12 December 2020

B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse

1 reference

12 December 2020

Genetic control of autoimmunity to acetylcholine receptors: role of Ia molecules

1 reference

12 December 2020

Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors

1 reference

12 December 2020

Genetic control of the immune response to haemoglobin. III. Variant A beta (bm12) but not Ae (D2.GD) Ia polypeptides alter immune responsiveness towards the alpha -subunit of human haemoglobin

1 reference

12 December 2020

Genetic control of experimental autoimmune myasthenia gravis in mice. II. Lymphocyte proliferative response to acetylcholine receptor is dependent on Lyt-1+23- cells

1 reference

12 December 2020

Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: correlated with cellular, humoral and clinical responses

1 reference

12 December 2020

The biology of myasthenia gravis

1 reference

12 December 2020

Tryptic peptide comparison of Ia antigen alpha and beta polypeptides from the I-A mutant B6.C-H-2bm12 and its congenic parental strain B6

1 reference

12 December 2020

Evidence for mutation in an I–A gene

1 reference

12 December 2020

Selective loss of antigen-specific Ir gene function in IA mutant B6.C-H-2bm12 is an antigen presenting cell defect

1 reference

12 December 2020

Increased expression of Ia and Thy-1 antigens on mitogen-activated murine spleen lymphocytes

1 reference

12 December 2020

Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors

1 reference

12 December 2020

Deficient T-cell mitogen response in murine experimental autoimmune myasthenia gravis: A defect in the adherent cell population

1 reference

12 December 2020

Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies

1 reference

12 December 2020

Serological and biochemical analysis of Ia molecules in the I-A mutant B6.C-H-2

1 reference

12 December 2020

Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automim

1 reference

12 December 2020

Ir gene function in an I-A subregion mutant B6.C-H-2bm12.

1 reference

12 December 2020

Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00372239

1 reference

30 May 2018

PubMed ID

3917973

1 reference

30 May 2018